Thabit International Pharma Private Limited

Founded in 2024 and headquartered in Maharashtra, India.

2024 | Mumbai, Maharashtra (India) | Active
Last Updated: December 09, 2024

Thabit International Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 1 Month

About Thabit International Pharma

Thabit International Pharma Private Limited (TIPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 January 2024 (One year and one month 2 days old ). Its registered office is in Mumbai, Maharashtra, India.

The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Mustafa Shaikh, Attesham Shaikh, and Mohmmad Ibrahim serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U46497MH2024PTC417484

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    18 Jan 2024

  • Date of AGM

    -

  • Date of Balance Sheet

    -

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Who are the key members and board of directors at Thabit International Pharma?

Executive Team (1)

NameDesignationAppointment DateStatus
Mustafa Shaikh Country flag representing In Managing Director18-Jan-2024Current

Board Members (2)

NameDesignationAppointment DateStatus
Attesham Shaikh Country flag representing In Director 18-Jan-2024Current
Mohmmad Ibrahim Country flag representing In Director 18-Jan-2024Current

Financial Performance of Thabit International Pharma.

Enhance accessibility to Thabit International Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Thabit International Pharma?

Unlock access to Thabit International Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Thabit International Pharma?

Unlock and access historical data on people associated with Thabit International Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Thabit International Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thabit International Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Thabit International Pharma

Recent activity within the organization

  • Director Appointment

    Mustafa Tanveer Shaikh was appointed as a Managing Director was appointed as a Managing Director on 18 Jan 2024 & has been associated with this company since 1 year 1 month .

    18 Jan 2024

  • Director Appointment

    Attesham Mohammed Aref Shaikh was appointed as a Director was appointed as a Director on 18 Jan 2024 & has been associated with this company since 1 year 1 month .

    18 Jan 2024

  • Director Appointment

    Mohmmad Irfan Khalid Shaikh Ibrahim was appointed as a Director was appointed as a Director on 18 Jan 2024 & has been associated with this company since 1 year 1 month .

    18 Jan 2024

  • Company Incorporation

    Thabit International Pharma Private Limited was registered on 18 Jan 2024 with Roc Mumbai & aged 1 year 1 month as per MCA records.

    18 Jan 2024

Frequently asked questions

  • Thabit International Pharma Private Limited was incorporated on 18 Jan 2024.

  • The authorized share capital of Thabit International Pharma Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Thabit International Pharma Private Limited.

    • Mustafa Tanveer Shaikh
    • Attesham Mohammed Aref Shaikh
    • Mohmmad Irfan Khalid Shaikh Ibrahim
  • As per Ministry of Corporate Affairs (Mca), the registered address of Thabit International Pharma Private Limited is 348/3/4 Ambika Ngr Park Site Vikhroli, Lowaer Depo India, Mumbai, Maharashtra, 400079.

  • The corporate identification number (CIN) of Thabit International Pharma Private Limited is U46497MH2024PTC417484 and the company number is as per Ministry of Corporate Affairs (MCA).